The latest news of OPM are here

All Financial News Poster Press Release Scientific paper Uncategorized
Filter by :
OPM announces its IPO through direct listing on Euronext Access + Paris
Financial
Press Release
Tue. 4 October 2022

OPM announces its IPO through direct listing on Euronext Access + Paris

Read more
The General Meeting of Oncodesign authorises the allocation of OPM
Financial
News
Press Release
Sat. 1 October 2022

The General Meeting of Oncodesign authorises the allocation of OPM

Read more
Euronext Paris authorises the listing of OPM shares
Financial
Press Release
Wed. 28 September 2022

Euronext Paris authorises the listing of OPM shares

Oncodesign and OPM announce that Euronext Paris S.A. has authorised the admission to listing on Euronext Access+ market...
Read more
Servier exercises the exclusive worldwide license option
News
Press Release
Mon. 26 September 2022

Servier exercises the exclusive worldwide license option

Read more
OPM and Servier announce a strategic collaboration
News
Press Release
Thu. 22 September 2022

OPM and Servier announce a strategic collaboration

Read more
ONCODESIGN announces the separation of its two business lines – Service and Biotech
News
Press Release
Fri. 1 July 2022

ONCODESIGN announces the separation of its two business lines – Service and Biotech

Read more
In vitro pharmacological profile of Compound A
Poster
Fri. 1 July 2022

In vitro pharmacological profile of Compound A

Read more
In vivo PK/PD profile of Compound A
Poster
Wed. 29 June 2022

In vivo PK/PD profile of Compound A

Read more
Development of small macrocyclic kinase inhibitors
Scientific paper
Thu. 31 March 2022

Development of small macrocyclic kinase inhibitors

Read more